Chattopadhyay S - Search Results

1

Autoimmunity to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease.

Ramirez-Montealegre D, Chattopadhyay S, Curran TM, Wasserfall C, Pritchard L, Schatz D, Petitto J, Hopkins D, She JX, Rothberg PG, Atkinson M, Pearce DA. Ramirez-Montealegre D, et al. Among authors: chattopadhyay s. Neurology. 2005 Feb 22;64(4):743-5. doi: 10.1212/01.WNL.0000151973.08426.7E. Neurology. 2005. PMID: 15728308

2

An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease.

Chattopadhyay S, Ito M, Cooper JD, Brooks AI, Curran TM, Powers JM, Pearce DA. Chattopadhyay S, et al. Hum Mol Genet. 2002 Jun 1;11(12):1421-31. doi: 10.1093/hmg/11.12.1421. Hum Mol Genet. 2002. PMID: 12023984

3

An autoantibody to GAD65 in sera of patients with juvenile neuronal ceroid lipofuscinoses.

Chattopadhyay S, Kriscenski-Perry E, Wenger DA, Pearce DA. Chattopadhyay S, et al. Neurology. 2002 Dec 10;59(11):1816-7. doi: 10.1212/01.wnl.0000041913.97883.8b. Neurology. 2002. PMID: 12473787 No abstract available.

4

Interaction with Btn2p is required for localization of Rsglp: Btn2p-mediated changes in arginine uptake in Saccharomyces cerevisiae.

Chattopadhyay S, Pearce DA. Chattopadhyay S, et al. Eukaryot Cell. 2002 Aug;1(4):606-12. doi: 10.1128/EC.1.4.606-612.2002. Eukaryot Cell. 2002. PMID: 12456008 Free PMC article.

5

Functional categorization of gene expression changes in the cerebellum of a Cln3-knockout mouse model for Batten disease.

Brooks AI, Chattopadhyay S, Mitchison HM, Nussbaum RL, Pearce DA. Brooks AI, et al. Among authors: chattopadhyay s. Mol Genet Metab. 2003 Jan;78(1):17-30. doi: 10.1016/s1096-7192(02)00201-9. Mol Genet Metab. 2003. PMID: 12559844

6

The yeast model for Batten disease: a role for Btn2p in the trafficking of the Golgi-associated vesicular targeting protein, Yif1p.

Chattopadhyay S, Roberts PM, Pearce DA. Chattopadhyay S, et al. Biochem Biophys Res Commun. 2003 Mar 14;302(3):534-8. doi: 10.1016/s0006-291x(03)00209-2. Biochem Biophys Res Commun. 2003. PMID: 12615067

7

Early changes in gene expression in two models of Batten disease.

Elshatory Y, Brooks AI, Chattopadhyay S, Curran TM, Gupta P, Ramalingam V, Hofmann SL, Pearce DA. Elshatory Y, et al. Among authors: chattopadhyay s. FEBS Lett. 2003 Mar 13;538(1-3):207-12. doi: 10.1016/s0014-5793(03)00162-5. FEBS Lett. 2003. PMID: 12633880 Free article.

8

Altered gene expression in the eye of a mouse model for batten disease.

Chattopadhyay S, Kingsley E, Serour A, Curran TM, Brooks AI, Pearce DA. Chattopadhyay S, et al. Invest Ophthalmol Vis Sci. 2004 Sep;45(9):2893-905. doi: 10.1167/iovs.04-0143. Invest Ophthalmol Vis Sci. 2004. PMID: 15326100

9

Elevation of Hook1 in a disease model of Batten disease does not affect a novel interaction between Ankyrin G and Hook1.

Weimer JM, Chattopadhyay S, Custer AW, Pearce DA. Weimer JM, et al. Among authors: chattopadhyay s. Biochem Biophys Res Commun. 2005 May 20;330(4):1176-81. doi: 10.1016/j.bbrc.2005.03.103. Biochem Biophys Res Commun. 2005. PMID: 15823567

10

Neural and extraneural expression of the neuronal ceroid lipofuscinoses genes CLN1, CLN2, and CLN3: functional implications for CLN3.

Chattopadhyay S, Pearce DA. Chattopadhyay S, et al. Mol Genet Metab. 2000 Sep-Oct;71(1-2):207-11. doi: 10.1006/mgme.2000.3056. Mol Genet Metab. 2000. PMID: 11001812 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,168 results

Search Page

Filters